Auctus Fund Management LLC Reports 9.9% Stake in BioRestorative Therapies, Inc. (BRTX)

On May 15, 2026, Auctus Fund Management LLC and associated reporting persons (Auctus Fund, LLC, Alfred Sollami, and Louis Posner) filed a Schedule 13G/A for BioRestorative Therapies, Inc. (BRTX). The filing discloses a beneficial ownership of 2,699,470 shares of common stock, representing 9.9% of the company. This holding consists of 1,155,914 directly held shares and 1,543,556 shares issuable upon the exercise of warrants. Notably, the reporting persons hold additional warrants for 1,498,718 shares that are currently unexercisable due to a 9.99% blocker provision. Without this restriction, their ownership would total 4,198,188 shares. This filing marks a significant increase from a previous 0% position, indicating a new substantial investment in the issuer. Auctus Fund Management LLC serves as the investment manager to Auctus Fund, LLC, with Alfred Sollami and Louis Posner exercising shared voting and dispositive power over the securities. The acquisition was made in the ordinary course of business without the intent to change or influence control of the issuer.